Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: Clinical and biologic activities in the phase 1 setting

Razelle Kurzrock, Hagop M. Kantarjian, Jorge E. Cortes, Neil Singhania, Deborah A. Thomas, Edward F. Wilson, John J. Wright, Emil J. Freireich, Moshe Talpaz, Saïd M. Sebti

Research output: Contribution to journalArticle

125 Scopus citations

Fingerprint Dive into the research topics of 'Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: Clinical and biologic activities in the phase 1 setting'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds